品牌:Quidel
貨號:A307
品名:Polyclonal Antiserum to Human C6 Protein
規(guī)格:2.00 mL
商品詳情參考文獻相關(guān)資料
產(chǎn)品介紹
品名
Polyclonal Antiserum to Human C6 Protein
貨號
A307
規(guī)格
2.0 mL
形式
Whole Antiserum
防腐劑
≤ 0.1% Sodium Azide
物種交叉反應(yīng)
Baboon, Dog, Cat, Rabbit, Rat, Horse
儲存
2°C to 8°C (≤ 30 days)
For long-term storage (> 30 days), aliquot and store at ≤ –20°C. Avoid repeated freeze-thaw.
使用說明
For Research Use Only. Not for use in diagnostic procedures
產(chǎn)品描述
Highly purified human C6 was isolated from normal serum and used to immunize goats. The anti-human C6 polyclonal antisera was tested against normal human plasma by double immunodiffusion, one-dimensional immunoelectrophoresis, quantitative radial immunodiffusion, and quantitative rocket immunoelectrophoresis. The antiserum was determined to be monospecific for C6 at varying concentrations.
背景
C6 is a plasma glycoprotein which is present in normal human serum/plasma at approximately 60 μg/mL. Primarily synthesized in the liver, C6 is a single-chain protein with a molecular weight of approximately 105 kD. With activation of the classical or alternative pathways of the complement system, C5 convertase cleaves the C5 chain into C5a and C5b. C5b remains bound to the convertase and will combine with C6 to form a C5b,6 complex. This complex normally interacts with C7 to form C5b,6,7 that becomes partially embedded in the target cell outer membrane.
應(yīng)用
Applications of the C6 polyclonal antisera have been evaluated by various research facilities, and include Western Blot, 1 IHC, 2,3 and ELISA. 4
參考文獻
1、Mollnes, T.E., et al. “Complement Activation in Septic Baboons Detected By Neoepitope-Specific Assasy for C3b/iC3b/C3c, C5a and the Terminal C5b-9 Complement Complex (TCC).” Clinical & Experimental Immunology (1993): 295-300.
2、Banz, Y., et al. “Attenuation of Myocardial Reperfusion Injury in Pigs by Mirococept, a Membrane-Targeted Complement Inhibitor Derived from Human CR1.” Cardiovascular Research (2007): 482-493.
3、Bongoni, A. “Functional Evaluation of Multiple Human Transgenes to Overcome Immunological and Coagulation Barriers Associate with Pig-to-Human Xenotransplantation.” Diss. University of Bern, Switzerland (2013). Web